--- title: Home description: New home page as of June 3rd, 2024 --- [![Logo](https://www.healthbioai.com/hubfs/HealthBio%20logo%20files%201%20of%202/Logo%20with%20white%20tagline.png) ](https://www.healthbioai.com/?hsLang=en) [ ORDER TEST ](https://longcovid.cellyhealth.com/index.php) ![Group 4](https://www.healthbioai.com/hubfs/Group%204.png) # Conquering Chronic Inflammation *Today* #### FOR A BETTER TOMORROW   [**FDA ACCEPTS HEALTHBIO LONG COVID CLINICAL TRIAL **](https://www.prnewswire.com/news-releases/healthbioai-announces-the-acceptance-by-the-federal-drug-administration-fda-to-proceed-with-a-randomized-clinical-trial-for-the-treatment-of-long-covidpost-acute-sequelae-of-covid-pasc-with-selzentry-maraviroc-in-combinati-302063138.html?tc=eml_cleartime)**JANUARY, 2024. ** [Clinical Trial Interest ?](https://www.healthbioai.com/trial_registratioin?hsLang=en) ![Group 1](https://www.healthbioai.com/hubfs/Group%201.png) ## We have identified a common thread in* chronic inflammatory diseases *through the use of *machine learning and AI-based precision diagnostics.*    This work has led to the creation of our **patented diagnostic testing and pharmaceutical treatment platform.** ![MOLECULE ILLU - WHITE](https://www.healthbioai.com/hubfs/MOLECULE%20ILLU%20-%20WHITE.png) ![IMAGE (3)](https://www.healthbioai.com/hubfs/IMAGE%20(3).png) [ View Case Study on Machine Learning ](https://www.healthbioai.com/hubfs/HealthBioAI/Long_COVID_Diagnostic_with_Differentiation_from_Ch.pdf?hsLang=en) ## *HealthBio has discovered the root cause and potential solution for diagnosing and treating chronic inflammatory diseases with patient's suffering from:* #### FATIGUE #### BRAIN FOG #### HEADACHE OR MIGRAINE #### JOINT PAIN #### MUSCLE PAIN AND WEAKNESS #### EXERCISE INTOLERANCE ![Group 2](https://www.healthbioai.com/hubfs/Group%202.png) ### OUR MISSION ## ***Develop solutions for millions of patients suffering from chronic inflammatory diseases worldwide*** ### TODAY: WE ARE **PURSUING THE DIAGNOSis AND TREATMENT ** of THESE CHRONIC INFLAMMATORY DISEASES AND DISORDERS ## INCIDENCE OF PREVALENT INFLAMMATORY ## DISEASES/DISORDERS IN THE US ![Group 47553](https://www.healthbioai.com/hubfs/Group%2047553.svg) #### LONG COVID 22Million ![Group 47554](https://www.healthbioai.com/hubfs/Group%2047554.svg) #### CHRONIC LYME 275K ![Group 47555](https://www.healthbioai.com/hubfs/Group%2047555.svg) #### FIBROMYALGIA 4Million ![Group 47552](https://www.healthbioai.com/hubfs/Group%2047552.svg) #### CHRONIC FATIGUE SYNDROME (ME/CFS) 2.5Million ## **Tomorrow:** Our ongoing research and development includes **Oncology, Alzheimer's** and **Autoimmune Diseases** ![Group 3](https://www.healthbioai.com/hubfs/Group%203.png) ## *Executing the same clinical algorithm developed with our* *machine learning and AI Health Data platform* *allows us to pursue diagnosis and treatment solutions for* *many other chronic inflammatory diseases.* ![Pic 1 for home page](https://www.healthbioai.com/hubfs/HealthBioAI/Pic%201%20for%20home%20page.png) ![Group 3 (1)](https://www.healthbioai.com/hubfs/Group%203%20(1).png) ## *HealthBio has cracked the code by identifying the **molecular root cause of Long COVID* *and potentially other inflammatory diseases.*   In Long Covid patients, the SI protein of the COVID-19 virus remains in their white blood cells, leading to a persistent immune response despite the absence of the active COVID-19 infection.   These white blood cells have many CCR5 and fractalkine receptors on their cell surface, which promote vascular inflammation and immune dysregulation through the monocytic-endothelial-platelet axis. We believe this is the primary root cause for adverse symptoms. ![user rating with photo-Mar-29-2024-09-48-45-3631-AM](https://www.healthbioai.com/hubfs/user%20rating%20with%20photo-Mar-29-2024-09-48-45-3631-AM.png) RESOURCE ARTICLE ## Frontiers in Immunology Persistent of Sars CoV-2 S1 Protein in CD16+ Monocytea in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection [READ MORE ![Group 47508](https://www.healthbioai.com/hubfs/Group%2047508.png) ](https://www.healthbioai.com/hubfs/HealthBioAI/fimmu-12-746021%20(4).pdf?hsLang=en) ![Group 2 (1)](https://www.healthbioai.com/hubfs/Group%202%20(1).png) ## HealthBioAI offers a comprehensive solution for patients suffering from Long Covid. **In today’s healthcare environment, the patient’s journey for diagnoses, treatment, ****and management of their Long Covid symptoms, can be quite overwhelming.** Without a clear root cause of the molecular etiology that can identify and differentiate Long Covid from other inflammatory diseases, the patient is often shuffled from one specialist to another to mitigate their symptoms. ***HealthBioAI is changing this paradigm by offering a clear, comprehensive path from diagnosis to treatment to management.***  ![MAIN CIRCLE](https://www.healthbioai.com/hubfs/MAIN%20CIRCLE.png) #### 1 TELEMED ENGAGEMENT HealthBioAI’s trained physicians and nurses provide optimal patient engagement via our Patient Concierge Services platform and virtual TeleMed consults. ![ICON - TELEMED](https://www.healthbioai.com/hubfs/ICON%20-%20TELEMED.png) #### 2 INCELL DX DIAGNOSTICS TEST Blood-based diagnostic assays (IncellKINE™) differentiate immune-mediated diseases including Long Covid, ME-CFS and chronic Lyme. ![ICON - DIAGNOSTICS](https://www.healthbioai.com/hubfs/ICON%20-%20DIAGNOSTICS.png) #### 4 PATIENT BIOMETRIC MONITORING Patented biometric wearable helps patients track symptoms to aid in optimizing care. ![ICON - BIOMETRIC DEVICE](https://www.healthbioai.com/hubfs/ICON%20-%20BIOMETRIC%20DEVICE.png) #### 3 RX THERAPEUTIC INNOVATION Our patented combination treatment has proven results in mitigating inflammation in immune-mediated diseases. HealthBioAI has a Double-blind, placebo controlled clinical trial accepted by FDA as 505B (2) trial. ![ICON - RX](https://www.healthbioai.com/hubfs/ICON%20-%20RX.png) Our Health Data platform feeds our AI and Machine Learning algorithms - which have generated **new diagnostics**, **predictive pathologic processes**, and **drug discovery**. ![UP ARROW](https://www.healthbioai.com/hubfs/UP%20ARROW.svg) Back to top ## ![Untitled (1080 x 350 px)-2](https://www.healthbioai.com/hubfs/Untitled%20(1080%20x%20350%20px)-2.png) ### Resources ![Message from CEO video](https://www.healthbioai.com/hubfs/HealthBioAI/Pic%202%20for%20home%20page.png) MESSAGE FROM CEO #### Dr. Bruce Patterson, Founder & CEO [ CLICK TO VIEW ![HealthBio logo (1080 x 1350 px) (1)](https://www.healthbioai.com/hubfs/HealthBio%20logo%20folder%201-29-25/HealthBio%20logo%20%20(1080%20x%201350%20px)%20(1).png) ](https://www.healthbioai.com/message-from-ceo?hsLang=en) ![Press Release](https://www.healthbioai.com/hubfs/user%20rating%20with%20photo-1.png) PRESS RELEASE #### FDA acceptance of clinical trial for Long Covid [ CLICK TO VIEW ![HealthBio logo (1080 x 1350 px) (1)](https://www.healthbioai.com/hubfs/HealthBio%20logo%20folder%201-29-25/HealthBio%20logo%20%20(1080%20x%201350%20px)%20(1).png) ](https://www.prnewswire.com/news-releases/healthbioai-announces-the-acceptance-by-the-federal-drug-administration-fda-to-proceed-with-a-randomized-clinical-trial-for-the-treatment-of-long-covidpost-acute-sequelae-of-covid-pasc-with-selzentry-maraviroc-in-combinati-302063138.html?tc=eml_cleartime) ![Webinar 10-8-2024 Understanding and Managing Long COVID](https://www.healthbioai.com/hubfs/Screenshot%202024-10-10%20at%201.40.20%20PM.png) WEBINAR RECORDING from PeploBio LTD on 10-8-24 #### Understanding and Managing Long COVID (Sponsored by PeploBio, UK) [ CLICK TO VIEW ![HealthBio logo (1080 x 1350 px) (1)](https://www.healthbioai.com/hubfs/HealthBio%20logo%20folder%201-29-25/HealthBio%20logo%20%20(1080%20x%201350%20px)%20(1).png) ](https://www.healthbioai.com/hubfs/HealthBioAI/Oct_Webinar_ver2.mp4?hsLang=en) 1. Davis H, Assaf G, McCorkell L, Wei H, Low R, Re'em Y, et al. Characterizing long COVID in a international cohort: 7 months of symptoms and their impact. EClinicalMedicine. (2021) 38:101019. do: 10.1016/j.eclinm.2021.10109   2. Nearly One in Five American Adults Who Have Had COVID-9 Still Have "Long COVID". https://www.cdc.gov/nchs/pressroom/nchs_press_releases/2022/20220622.html   3. Worldometer: COVID-19 CORONAVIRUS PANDEMIC. https://www.worldometers.info/coronavirus/e   4. Surveillance for Lyme Disease - United States, 2008-2015 https://www.cdc.gov/mmwr/volumes/66/ss/ss6622al.htm?s_cid=ss6622al_W   5. Arthritis Types: Fibromyalgia. https://www.cdc.gov/arthritis/types/fibromyalgia.htm   6. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. https://www.cdc.gov/me-cfs/index.html